Zhixin Haozheng
Suzhou
About Zhixin Haozheng
Zhixin Haozheng is an inventor of regenerating islet technology. The company focuses on in vitro regeneration of human tissues and organs, with the major pipeline consisting of regenerative islets that can be implanted to cure diabetes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $27.8M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2025)
- Website: endocell.cncn
Industries & Categories
Diabetes, Health Care
Canonical: https://fsome.com/organization/zhixin-haozheng-1905 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.